Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:12 pm
Unchanged
13GCrinetics Pharmaceuticals, Inc.
CRNX
ORBIMED ADVISORS LLC3,196,876
5.9%
0
(Unchanged)
View
2023-02-14
4:06 pm
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
BRAIDWELL LP3,469,674
6.45%
3,469,674increase
(New Position)
View
2023-02-14
11:58 am
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
BIOTECHNOLOGY VALUE FUND L P2,736,613
5.1%
-267,266decrease
(-8.90%)
View
2023-02-09
09:59 am
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
FMR LLC1,883,118
3.499%
-1,839,176decrease
(-49.41%)
View
2023-02-08
11:32 am
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
DRIEHAUS CAPITAL MANAGEMENT LLC5,624,744
10.45%
831,106increase
(+17.34%)
View
2023-02-06
2:51 pm
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
WELLINGTON MANAGEMENT GROUP LLP2,804,485
5.21%
2,804,485increase
(New Position)
View
2023-01-31
1:58 pm
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
BlackRock Inc.
BLK
3,917,489
7.3%
641,319increase
(+19.58%)
View
2022-04-25
7:02 pm
Unchanged
13DCrinetics Pharmaceuticals, Inc.
CRNX
PERCEPTIVE ADVISORS LLC5,333,532
10%
0
(Unchanged)
View
2022-04-20
9:17 pm
Purchase
13DCrinetics Pharmaceuticals, Inc.
CRNX
PERCEPTIVE ADVISORS LLC5,333,532
10%
1,674,151increase
(+45.75%)
View
2022-02-14
09:08 am
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
Deep Track Capital LP1,900,000
4%
1,334increase
(+0.07%)
View
2022-02-11
5:22 pm
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
Vivo Capital VIII LLC0
0%
-1,819,600decrease
(Position Closed)
View
2022-02-11
4:19 pm
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
ORBIMED ADVISORS LLC3,196,876
6.7%
443,309increase
(+16.10%)
View
2022-02-10
8:21 pm
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
Versant Venture Capital V L.P.382,961
0.8%
-1,512,041decrease
(-79.79%)
View
2022-02-10
4:30 pm
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
Struthers Richard Scott1,978,334
4.2%
274,339increase
(+16.10%)
View
2022-02-03
4:41 pm
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
BlackRock Inc.
BLK
3,276,170
6.9%
1,162,975increase
(+55.03%)
View
2022-01-10
1:26 pm
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
FMR LLC3,722,294
7.836%
-1,216,055decrease
(-24.62%)
View
2022-01-10
11:09 am
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
DRIEHAUS CAPITAL MANAGEMENT LLC4,793,638
10.09%
4,793,638increase
(New Position)
View
2021-10-29
4:29 pm
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
BIOTECHNOLOGY VALUE FUND L P3,003,879
6.5%
3,003,879increase
(New Position)
View
2021-04-22
5:56 pm
Purchase
13GCrinetics Pharmaceuticals, Inc.
CRNX
Deep Track Capital LP1,898,666
5.05%
1,898,666increase
(New Position)
View
2021-02-16
4:39 pm
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
RA CAPITAL MANAGEMENT L.P.564,102
1.7%
-1,311,107decrease
(-69.92%)
View
Goto 0, 1, 2, Next